Cargando…
Protease-activated receptor 1 as a potential therapeutic target for COVID-19
Acute respiratory disease caused by a novel coronavirus (SARS-CoV-2) has spread all over the world, since its discovery in 2019, Wuhan, China. This disease is called COVID-19 and already killed over 1 million people worldwide. The clinical symptoms include fever, dry cough, dyspnea, headache, dizzin...
Autores principales: | Rovai, Emanuel S., Alves, Tomaz, Holzhausen, Marinella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746952/ https://www.ncbi.nlm.nih.gov/pubmed/33302737 http://dx.doi.org/10.1177/1535370220978372 |
Ejemplares similares
-
Osteogenesis in human periodontal ligament stem cell sheets is enhanced by the protease-activated receptor 1 (PAR(1)) in vivo
por: Alves, Tomaz, et al.
Publicado: (2022) -
Therapeutic potential of periodontal ligament stem cells
por: Queiroz, Aline, et al.
Publicado: (2021) -
Protease-Activated Receptor Type 1 Activation Enhances Osteogenic Activity in Human Periodontal Ligament Stem Cells
por: Rovai, Emanuel Silva, et al.
Publicado: (2019) -
The Role of Proteinase-Activated Receptors 1 and 2 in the Regulation of Periodontal Tissue Metabolism and Disease
por: Rovai, E. S., et al.
Publicado: (2017) -
ARF-BP1 as a potential therapeutic target
por: Chen, D, et al.
Publicado: (2006)